Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria

The recently revised World Health Organization (WHO) classification of myeloid neoplasms recognizes prefibrotic myelofibrosis (prePMF) as a distinct entity, characterized by well-defined histopathologic features together with minor clinical criteria (leukocytes, anemia, increased LDH, splenomegaly)....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Rumi, Elisa, Boveri, Emanuela, Bellini, Marta, Pietra, Daniela, Ferretti, Virginia V., Sant’Antonio, Emanuela, Cavalloni, Chiara, Casetti, Ilaria C., Roncoroni, Elisa, Ciboddo, Michele, Benvenuti, Pietro, Landini, Benedetta, Fugazza, Elena, Troletti, Daniela, Astori, Cesare, Cazzola, Mario
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731910/
https://ncbi.nlm.nih.gov/pubmed/29254200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21594
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi